These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9148412)

  • 81. Non-antibiotic prevention of urinary tract infection.
    Hagberg L; Leffler H; Svanborg Edén C
    Infection; 1985; 13 Suppl 2():S196-201. PubMed ID: 3902654
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Replicated divergent selection of broiler chickens for high or low early antibody response to Escherichia coli vaccination.
    Leitner G; Uni Z; Cahaner A; Gutman M; Heller ED
    Poult Sci; 1992 Jan; 71(1):27-37. PubMed ID: 1539021
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunogenicity of Escherichia coli O antigen in upper urinary tract infection.
    Whitworth JA; Fairley KF; O'Keefe CM; Miller TE
    Kidney Int; 1975 Nov; 8(5):316-9. PubMed ID: 1104969
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Urinary tract infection: immunological aspects.
    Girão MJ; Baracat EC; Lima GR
    Int Urogynecol J Pelvic Floor Dysfunct; 2002; 13(3):195-7. PubMed ID: 12140717
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Vaccination experiments on pregnant mice with E. coli vaccines prepared from septicaemic and enteropathogenic strains of E. coli.
    Dam A
    Acta Vet Scand; 1973 May; 14(5):691-9. PubMed ID: 4589492
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Vaginal immunization against urinary tract infection.
    Uehling DT; Jensen J; Balish E
    J Urol; 1982 Dec; 128(6):1382-4. PubMed ID: 6759690
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
    Nayir A; Emre S; Sirin A; Bulut A; Alpay H; Tanman F
    Vaccine; 1995 Aug; 13(11):987-90. PubMed ID: 8525693
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment.
    Sánchez-Ramón S; Fernández-Paredes L; Saz-Leal P; Diez-Rivero CM; Ochoa-Grullón J; Morado C; Macarrón P; Martínez C; Villaverde V; de la Peña AR; Conejero L; Hernández-Llano K; Cordero G; Fernández-Arquero M; Gutierrez BF; Candelas G
    Front Immunol; 2021; 12():675735. PubMed ID: 34149711
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An "omics" approach to uropathogenic Escherichia coli vaccinology.
    Sivick KE; Mobley HL
    Trends Microbiol; 2009 Oct; 17(10):431-2. PubMed ID: 19758805
    [No Abstract]   [Full Text] [Related]  

  • 90. What hygiene measures are advisable to prevent recurrent urinary tract infection and what evidence is there to support this advice?
    Winberg J
    Pediatr Nephrol; 1994 Dec; 8(6):652. PubMed ID: 7696096
    [No Abstract]   [Full Text] [Related]  

  • 91. Vaccines against intracellular pathogens.
    Barletta RG; Donis RO; Chacón O; Shams H; Cirillo JD
    Subcell Biochem; 2000; 33():559-99. PubMed ID: 10804870
    [No Abstract]   [Full Text] [Related]  

  • 92. Vaginal vaccine for recurrent urinary-tract infections.
    Das P
    Lancet Infect Dis; 2002 Feb; 2(2):68. PubMed ID: 11901648
    [No Abstract]   [Full Text] [Related]  

  • 93. Oral vaccination.
    Dougan G; Maskell D; O'Callaghan D; Chatfield S; Charles I; Hormaeche C
    Antonie Van Leeuwenhoek; 1988; 54(5):447-51. PubMed ID: 3060010
    [No Abstract]   [Full Text] [Related]  

  • 94. Novel vaccine strategies.
    Babiuk LA; Babiuk SL; Baca-Estrada ME
    Adv Virus Res; 2002; 58():29-80. PubMed ID: 12205782
    [No Abstract]   [Full Text] [Related]  

  • 95. [Experience with use of starch in a suspension medium for production of dry colibacterin].
    Kozyreva MI; Fisher GM; Piatlina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Feb; 47(2):129-31. PubMed ID: 4924070
    [No Abstract]   [Full Text] [Related]  

  • 96. Antibody formation after vaccination against salmonellosis in adults and geriatric patients with urinary tract infection.
    Sourander LB; Kaarsalo E; Kasanen A
    Gerontol Clin (Basel); 1967; 9(2):103-6. PubMed ID: 4861603
    [No Abstract]   [Full Text] [Related]  

  • 97. [Endogenous stimulators of immunogenesis].
    Klemparskaia NN; Ulanova AM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):108-9. PubMed ID: 7269910
    [No Abstract]   [Full Text] [Related]  

  • 98. Immunological and formulation design considerations for subunit vaccines.
    Newman MJ; Powell MF
    Pharm Biotechnol; 1995; 6():1-42. PubMed ID: 7551216
    [No Abstract]   [Full Text] [Related]  

  • 99. Urinary tract infection vaccines - the 'burning' issue.
    Yang B; Foley S
    BJU Int; 2019 May; 123(5):743-744. PubMed ID: 31008561
    [No Abstract]   [Full Text] [Related]  

  • 100. The Uses of Bacterial Vaccines in Urinary Disease.
    Macgowan G
    Cal State J Med; 1910 Mar; 8(3):79-84. PubMed ID: 18734901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.